Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Apotex
FDA Approves AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE — Apotex Corp.

On April 28, the FDA approved a generic version of the nasal spray AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE manufactured by Apotex Corp., r...

Radius
FDA Approves TYMLOS — Radius Health, Inc.

Radius Health Inc.'s TYMLOS (abaloparatide) received FDA approval on April 28, 2017, introducing a new subcutaneous anabolic therapy that directly cha...

Azurity
FDA Approves XATMEP — Azurity Pharmaceuticals, Inc.

# FDA Approves Azurity Pharmaceuticals' XATMEP Oral Methotrexate Formulation Azurity Pharmaceuticals has received FDA approval for XATMEP (methotrexa...

Protega
FDA Approves ROXYBOND — Protega Pharmaceuticals Inc

Protega Pharmaceuticals Inc. has received FDA approval for Roxycbond (oxycodone hydrochloride), a crucial strategic addition for the company intended ...

Unichem
FDA Approves PIROXICAM — Unichem Pharmaceuticals (USA), Inc.

# FDA Approves Piroxicam Generic for Unichem Pharmaceuticals Unichem Pharmaceuticals (USA), Inc. received FDA approval for its generic piroxicam oral...

RISING
FDA Approves Unknown Drug — RISING

# FDA Approves Rising Pharmaceuticals' Generic Drug Application Rising Pharmaceuticals has received FDA approval for an abbreviated new drug applicat...

RISING
FDA Approves Unknown Drug — RISING

# FDA Approves Rising Pharmaceuticals' Generic Drug Application Rising Pharmaceuticals has received FDA approval for ANDA200217, expanding its generi...

Genentech,
FDA Approves OCREVUS — Genentech, Inc.

# FDA Approves Genentech's OCREVUS for Multiple Sclerosis Treatment Genentech announced FDA approval of OCREVUS (ocrelizumab), an intravenous monoclo...

Rhodes
FDA Approves BUPRENORPHINE — Rhodes Pharmaceuticals LLC

Rhodes Pharmaceuticals LLC has received approval for its Abbreviated New Drug Application (ANDA) for Buprenorphine Hydrochloride sublingual tablets, p...

Upsher-Smith
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Upsher-Smith Laboratories, LLC

Upsher-Smith Laboratories, LLC announced FDA approval of the ANDA for Hydrocodone Bitartrate and Acetaminophen, adding another generic option for this...

EMD
FDA Approves Unknown Drug — EMD SERONO INC

On March 23, 2017, EMD Serono received FDA approval for the drug, a move which positions the company to capitalize on increased demand within this the...

Camber
FDA Approves OXYCODONE AND ACETAMINOPHEN — Camber Pharmaceuticals, Inc.

Camber Pharmaceuticals gained FDA approval for its ANDA207419 formulation of oxycodone and acetaminophen tablets, granting the company the rights to s...

Aurobindo
FDA Approves TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN — Aurobindo Pharma Limited

The FDA has granted approval to Aurobindo Pharma Limited for its generic Tramadol Hydrochloride oral product, marking a new competitive entry into the...

Accord
FDA Approves OXALIPLATIN — Accord Healthcare Inc.

# FDA Approves Generic Oxaliplatin from Accord Healthcare Inc. Accord Healthcare Inc. received FDA approval for a generic version of oxaliplatin, an ...

Ascend
FDA Approves ROSUVASTATIN CALCIUM — Ascend Laboratories, LLC

On March 21, 2017, Ascend Laboratories, LLC received FDA approval for the ANDA for rosuvastatin calcium, a generic version of the widely used choleste...

TEVA
FDA Approves Unknown Drug — TEVA PHARMS USA

TEVA PHARMS USA reported the approval of its Abbreviated New Drug Application (ANDA 205807) on March 10, 2017, a milestone that positions the company ...

AMNEAL
FDA Approves Unknown Drug — AMNEAL PHARMS

On February 28, 2017, Amneal Pharmaceuticals received approval for ANDA 204741, a development that positions the company in significant market trial r...

RISING
FDA Approves Unknown Drug — RISING

Rising has received final FDA approval for its Abbreviated New Drug Application (ANDA #204043), positioning itself for entry into the market once the ...

ASTRAZENECA
FDA Approves Unknown Drug — ASTRAZENECA AB

# FDA Approves AstraZeneca Drug, Expanding Treatment Options in Key Therapeutic Area The U.S. Food and Drug Administration has approved AstraZeneca A...

Lupin
FDA Approves OXYCODONE AND ACETAMINOPHEN — Lupin Pharmaceuticals,Inc.

**FDA Approves ANDA for Lupin’s Oxycodone and Acetaminophen Combination Product** On February 24, 2017, the FDA approved Lupin Pharmaceuticals' Abbre...